Key facts
- Combat Medical (Devices and Supplies)’s last known valuation is $44.3M (Mar 2026).
- It has raised $18.0M; the latest was Later Stage VC ($3.5M) in Mar 2026.
- Notable investors include Innovate UK, European Commission, NW Angel, Oxford Technology Management, T & J Meyer Family Foundation — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Combat Medical (Devices and Supplies)
- ·The full record, as it builds
Funding rounds
No funding rounds for Combat Medical (Devices and Supplies) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Combat Medical (Devices and Supplies)
Developer of a hyperthermic delivery system designed to offer treatments to patients with bladder and peritoneal cancers. The company's system provides an effective, accurate, and affordable technology that optimizes the intravesical instillation of chemotherapy and achieves real, measurable results, enabling healthcare providers to maximize the efficacy of the chemotherapy treatment.
- Sector
- Healthcare
- HQ
- Saint Albans, United Kingdom
- Founded
- 2012
- Employees
- 24
- Website
- combatcancer.com/
- Ownership
- Privately Held (backing)
Combat Medical (Devices and Supplies) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Combat Medical (Devices and Supplies) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Combat Medical (Devices and Supplies) in its N-PORT filings yet. We sweep new filings monthly.